These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 33300431)

  • 1. DCAF13 promotes triple-negative breast cancer metastasis by mediating DTX3 mRNA degradation.
    Liu J; Li H; Mao A; Lu J; Liu W; Qie J; Pan G
    Cell Cycle; 2020 Dec; 19(24):3622-3631. PubMed ID: 33300431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DCAF13 promotes breast cancer cell proliferation by ubiquitin inhibiting PERP expression.
    Shan BQ; Wang XM; Zheng L; Han Y; Gao J; Lv MD; Zhang Y; Liu YX; Zhang H; Chen HS; Ao L; Zhang YL; Lu X; Wu ZJ; Xu Y; Che X; Heger M; Cheng SQ; Pan WW; Zhang X
    Cancer Sci; 2022 May; 113(5):1587-1600. PubMed ID: 35178836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin promotes breast cancer cell migration and invasion via DCAF13.
    Sun Z; Zhou D; Yang J; Zhang D
    FEBS Open Bio; 2022 Jan; 12(1):221-230. PubMed ID: 34775691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
    Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
    J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CRL4-DCAF13 ubiquitin E3 ligase supports oocyte meiotic resumption by targeting PTEN degradation.
    Zhang J; Zhang YL; Zhao LW; Pi SB; Zhang SY; Tong C; Fan HY
    Cell Mol Life Sci; 2020 Jun; 77(11):2181-2197. PubMed ID: 31492966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer.
    Zhou L; Wang D; Sheng D; Xu J; Chen W; Qin Y; Du R; Yang X; He X; Xie N; Liu S; Zhang L
    Theranostics; 2020; 10(5):2405-2421. PubMed ID: 32104513
    [No Abstract]   [Full Text] [Related]  

  • 7. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA.
    Luo N; Zhang K; Li X; Hu Y
    J Cell Biochem; 2020 Oct; 121(10):4176-4187. PubMed ID: 31922280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMP2 and IMP3 cooperate to promote the metastasis of triple-negative breast cancer through destabilization of progesterone receptor.
    Kim HY; Ha Thi HT; Hong S
    Cancer Lett; 2018 Feb; 415():30-39. PubMed ID: 29217458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
    Li YY; Zheng XH; Deng AP; Wang Y; Liu J; Zhou Q; Cheng GY; Jiang Q
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA.
    Block CJ; Mitchell AV; Wu L; Glassbrook J; Craig D; Chen W; Dyson G; DeGracia D; Polin L; Ratnam M; Gibson H; Wu G
    Oncogene; 2021 Nov; 40(46):6430-6442. PubMed ID: 34608266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer.
    Fan Y; Wang J; Jin W; Sun Y; Xu Y; Wang Y; Liang X; Su D
    Mol Cancer; 2021 Feb; 20(1):25. PubMed ID: 33530981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.
    Ji H; Sang M; Liu F; Ai N; Geng C
    Pathol Res Pract; 2019 Apr; 215(4):697-704. PubMed ID: 30611621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells.
    Wu J; Li WZ; Huang ML; Wei HL; Wang T; Fan J; Li NL; Ling R
    Biochem Biophys Res Commun; 2017 Jan; 483(1):10-16. PubMed ID: 28069384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma.
    Wei S; Xing J; Chen J; Chen L; Lv J; Chen X; Li T; Yu T; Wang H; Wang K; Yu W
    J Exp Clin Cancer Res; 2024 Jan; 43(1):3. PubMed ID: 38163876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Function and prognosis analysis of nucleolus protein DCAF13 in breast cancer.
    Wang M; Fu L; Tian J; Zhang Y; Rossi L; Wang K
    Transl Cancer Res; 2023 Dec; 12(12):3744-3751. PubMed ID: 38197079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells.
    Ling Y; Cao Q; Liu Y; Zhao J; Zhao Y; Li K; Chen Z; Du X; Huo X; Kang H; Chen Z
    Breast Cancer; 2021 Mar; 28(2):368-378. PubMed ID: 33047272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-300 Regulates the Ubiquitination of PTEN through the CRL4B
    Chen Z; Zhang W; Jiang K; Chen B; Wang K; Lao L; Hou C; Wang F; Zhang C; Shen H
    Mol Ther Nucleic Acids; 2018 Mar; 10():254-268. PubMed ID: 29499938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid Zinc Finger 1 (MZF1) Maintains the Mesenchymal Phenotype by Down-regulating IGF1R/p38 MAPK/ERα Signaling Pathway in High-level MZF1-expressing TNBC cells.
    Yue CH; Liu JY; Chi CS; Hu CW; Tan KT; Huang FM; Pan YR; Lin KI; Lee CJ
    Anticancer Res; 2019 Aug; 39(8):4149-4164. PubMed ID: 31366500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.